1. Home
  2. ALLR vs WFF Comparison

ALLR vs WFF Comparison

Compare ALLR & WFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.45

Market Cap

21.5M

Sector

Health Care

ML Signal

HOLD

Logo WF Holding Limited Ordinary Shares

WFF

WF Holding Limited Ordinary Shares

HOLD

Current Price

$2.30

Market Cap

20.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLR
WFF
Founded
2004
1984
Country
United States
Malaysia
Employees
8
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
21.5M
20.9M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
ALLR
WFF
Price
$1.45
$2.30
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
64.6K
6.1M
Earning Date
05-15-2026
05-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$320,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.18
52 Week High
$2.35
$10.71

Technical Indicators

Market Signals
Indicator
ALLR
WFF
Relative Strength Index (RSI) 62.51 52.10
Support Level $1.21 $0.90
Resistance Level $1.55 $3.08
Average True Range (ATR) 0.10 1.62
MACD 0.01 -0.00
Stochastic Oscillator 72.22 9.55

Price Performance

Historical Comparison
ALLR
WFF

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings, and other custom-made FRP products. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance. Geographically, the company generates the majority of its revenue from Australia.

Share on Social Networks: